Glaukos Corp. Hits Day High with 13.89% Surge in Strong Intraday Performance

Glaukos Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance, gaining 13.89% on October 30, 2025. The stock reached an intraday high of USD 102.80, marking a notable achievement in its trading activity for the day.
In terms of performance metrics, Glaukos Corp. has shown a 16.66% increase over the past week, while its monthly performance stands at 7.66%. However, the company has faced challenges over the longer term, with a one-year decline of 36.69% and a year-to-date drop of 41.44%. Despite these setbacks, the stock has demonstrated resilience with a 52.03% increase over the past three years.

The company maintains a strong institutional presence, with 100% institutional holdings, indicating a robust backing from investors who typically possess greater analytical resources. While Glaukos Corp. has reported negative EBITDA and a return on equity of -12.13%, its recent performance highlights a moment of activity that may reflect underlying trends in the market.